Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Xiangyang Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8926-9887; OpenAlex author ID A5029123913. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper

Papers 1

  1. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism. Co-author DOI 10.18632/aging.203725↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanyi Xiao · 1 shared paper, 2021 · strength 0.13
  2. Hangcheng Guo · 1 shared paper, 2021 · strength 0.13
  3. Hengyue Zhu · 1 shared paper, 2021 · strength 0.13
  4. Yunfeng Shan · 1 shared paper, 2021 · strength 0.13
  5. Yangyang Guo · 1 shared paper, 2021 · strength 0.13
  6. Yongheng Bai · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.